The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| AGILE THERAPEUTICS INC | COM | 00847L100 | 18,529 | 2,983,797 | SH | SOLE | 2,983,797 | 0 | 0 | ||
| CATALENT INC | COM | 148806102 | 19,087 | 715,673 | SH | SOLE | 715,673 | 0 | 0 | ||
| CEMPRA INC | COM | 15130J109 | 20,902 | 1,193,060 | SH | SOLE | 1,193,060 | 0 | 0 | ||
| CHIMERIX INC | COM | 16934W106 | 2,417 | 472,943 | SH | SOLE | 472,943 | 0 | 0 | ||
| ESPERION THERAPEUTICS INC NE | COM | 29664W105 | 27,684 | 1,637,125 | SH | SOLE | 1,637,125 | 0 | 0 | ||
| INTERSECT ENT INC | COM | 46071F103 | 6,650 | 350,000 | SH | SOLE | 350,000 | 0 | 0 | ||
| LOMBARD MED INC | COM | G55598109 | 931 | 886,363 | SH | SOLE | 886,363 | 0 | 0 | ||
| LOXO ONCOLOGY INC | COM | 548862101 | 103,793 | 3,796,362 | SH | SOLE | 3,796,362 | 0 | 0 | ||
| PERNIX THERAPEUTICS HLDGS IN | COM | 71426V108 | 2,111 | 2,010,000 | SH | SOLE | 2,010,000 | 0 | 0 | ||
| ROKA BIOSCIENCE INC | COM | 775431109 | 354 | 512,920 | SH | SOLE | 512,920 | 0 | 0 | ||
| T2 BIOSYSTEMS INC | COM | 89853L104 | 27,914 | 2,830,992 | SH | SOLE | 2,830,992 | 0 | 0 | ||
| TRANSENTERIX INC | COM NEW | 89366M201 | 35,427 | 8,335,819 | SH | SOLE | 8,335,819 | 0 | 0 | ||
| VERSARTIS INC | COM | 92529L102 | 18,282 | 2,279,568 | SH | SOLE | 2,279,568 | 0 | 0 | ||
| ZELTIQ AESTHETICS INC | COM | 98933Q108 | 57,132 | 2,103,528 | SH | SOLE | 2,103,528 | 0 | 0 | ||
| DERMIRA INC | COM | 24983L104 | 20,077 | 970,823 | SH | SOLE | 970,823 | 0 | 0 | ||
| PARATEK PHARMACEUTICALS INC | COM | 699374302 | 10,356 | 682,680 | SH | SOLE | 682,680 | 0 | 0 | ||
| ADMA BIOLOGICS INC | COM | 000899104 | 29,190 | 3,608,171 | SH | SOLE | 3,608,171 | 0 | 0 | ||
| AIMMUNE THERAPEUTICS INC | COM | 00900T107 | 40,544 | 2,990,000 | SH | SOLE | 2,990,000 | 0 | 0 | ||
| CYNAPSUS THERAPEUTICS INC | COM | 23257Y859 | 12,154 | 1,021,381 | SH | SOLE | 1,021,381 | 0 | 0 | ||
| CIDARA THERAPEUTICS INC | COM | 171757107 | 12,947 | 1,019,455 | SH | SOLE | 1,019,455 | 0 | 0 | ||
| PERNIX THERAPEUTICS HLDGS IN | DEBT | 71426VAJ7 | 825 | 2,500,000 | PRN | SOLE | 2,500,000 | 0 | 0 | ||
| VIEWRAY INC | COM | 92672L107 | 32,086 | 7,461,923 | SH | SOLE | 7,461,923 | 0 | 0 | ||